Cargando…

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo

BACKGROUND: The involvement of NF-κB signaling in prostate cancer (PCa) has largely been established through the study of the classical p65 subunit. Nuclear localization of p65 in PCa patient tissues has been shown to correlate with biochemical recurrence, while in vitro studies have demonstrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Labouba, Ingrid, Poisson, Alexis, Lafontaine, Julie, Delvoye, Nathalie, Gannon, Philippe O, Le Page, Cécile, Saad, Fred, Mes-Masson, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364035/
https://www.ncbi.nlm.nih.gov/pubmed/25788857
http://dx.doi.org/10.1186/1475-2867-14-67
_version_ 1782362011248623616
author Labouba, Ingrid
Poisson, Alexis
Lafontaine, Julie
Delvoye, Nathalie
Gannon, Philippe O
Le Page, Cécile
Saad, Fred
Mes-Masson, Anne-Marie
author_facet Labouba, Ingrid
Poisson, Alexis
Lafontaine, Julie
Delvoye, Nathalie
Gannon, Philippe O
Le Page, Cécile
Saad, Fred
Mes-Masson, Anne-Marie
author_sort Labouba, Ingrid
collection PubMed
description BACKGROUND: The involvement of NF-κB signaling in prostate cancer (PCa) has largely been established through the study of the classical p65 subunit. Nuclear localization of p65 in PCa patient tissues has been shown to correlate with biochemical recurrence, while in vitro studies have demonstrated that the classical NF-κB signaling pathway promotes PCa progression and metastatic potential. More recently, the nuclear location of RelB, a member of the alternative NF-κB signaling, has also been shown to correlate with the Gleason score. The current study aims to clarify the role of alternative NF-κB in PCa cells by exploring, in vitro and in vivo, the effects of RelB overexpression on PCa biology. METHODS: Using a lentivirus-expression system, we constitutively overexpressed RelB or control GFP into 22Rv1 cells and monitored alternative transcriptional NF-κB activity. In vivo, tumor growth was assessed after the injection of 22Rv1-derived cells into SCID mice. In vitro, the impact of RelB on 22Rv1 cell proliferation was evaluated in monolayer culture. The anchorage-independent cell growth of derived-22Rv1 cells was assessed by soft agar assay. Apoptosis and autophagy were evaluated by Western blot analysis in 22Rv1-derived cells cultured in suspension using poly-HEMA pre-coated dishes. RESULTS: The overexpression of RelB in 22Rv1 cells induced the constitutive activation of the alternative NF-κB pathway. In vivo, RelB expression caused a lag in the initiation of 22Rv1-induced tumors in SCID mice. In vitro, RelB stimulated the proliferation of 22Rv1 cells and reduced their ability to grow in soft agar. These observations may be reconciled by our findings that, when cultured in suspension on poly-HEMA pre-coated dishes, 22Rv1 cells expressing RelB were more susceptible to cell death, and more specifically to autophagy controlled death. CONCLUSIONS: This study highlights a role of the alternative NF-κB pathway in proliferation and the controlled autophagy. Thus, the interplay of these properties may contribute to tumor survival in stress conditions while promoting PCa cells growth contributing to the overall tumorigenicity of these cells.
format Online
Article
Text
id pubmed-4364035
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43640352015-03-19 The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo Labouba, Ingrid Poisson, Alexis Lafontaine, Julie Delvoye, Nathalie Gannon, Philippe O Le Page, Cécile Saad, Fred Mes-Masson, Anne-Marie Cancer Cell Int Primary Research BACKGROUND: The involvement of NF-κB signaling in prostate cancer (PCa) has largely been established through the study of the classical p65 subunit. Nuclear localization of p65 in PCa patient tissues has been shown to correlate with biochemical recurrence, while in vitro studies have demonstrated that the classical NF-κB signaling pathway promotes PCa progression and metastatic potential. More recently, the nuclear location of RelB, a member of the alternative NF-κB signaling, has also been shown to correlate with the Gleason score. The current study aims to clarify the role of alternative NF-κB in PCa cells by exploring, in vitro and in vivo, the effects of RelB overexpression on PCa biology. METHODS: Using a lentivirus-expression system, we constitutively overexpressed RelB or control GFP into 22Rv1 cells and monitored alternative transcriptional NF-κB activity. In vivo, tumor growth was assessed after the injection of 22Rv1-derived cells into SCID mice. In vitro, the impact of RelB on 22Rv1 cell proliferation was evaluated in monolayer culture. The anchorage-independent cell growth of derived-22Rv1 cells was assessed by soft agar assay. Apoptosis and autophagy were evaluated by Western blot analysis in 22Rv1-derived cells cultured in suspension using poly-HEMA pre-coated dishes. RESULTS: The overexpression of RelB in 22Rv1 cells induced the constitutive activation of the alternative NF-κB pathway. In vivo, RelB expression caused a lag in the initiation of 22Rv1-induced tumors in SCID mice. In vitro, RelB stimulated the proliferation of 22Rv1 cells and reduced their ability to grow in soft agar. These observations may be reconciled by our findings that, when cultured in suspension on poly-HEMA pre-coated dishes, 22Rv1 cells expressing RelB were more susceptible to cell death, and more specifically to autophagy controlled death. CONCLUSIONS: This study highlights a role of the alternative NF-κB pathway in proliferation and the controlled autophagy. Thus, the interplay of these properties may contribute to tumor survival in stress conditions while promoting PCa cells growth contributing to the overall tumorigenicity of these cells. BioMed Central 2014-07-28 /pmc/articles/PMC4364035/ /pubmed/25788857 http://dx.doi.org/10.1186/1475-2867-14-67 Text en Copyright © 2014 Labouba et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Primary Research
Labouba, Ingrid
Poisson, Alexis
Lafontaine, Julie
Delvoye, Nathalie
Gannon, Philippe O
Le Page, Cécile
Saad, Fred
Mes-Masson, Anne-Marie
The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
title The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
title_full The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
title_fullStr The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
title_full_unstemmed The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
title_short The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
title_sort relb alternative nf-kappab subunit promotes autophagy in 22rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364035/
https://www.ncbi.nlm.nih.gov/pubmed/25788857
http://dx.doi.org/10.1186/1475-2867-14-67
work_keys_str_mv AT laboubaingrid therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT poissonalexis therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT lafontainejulie therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT delvoyenathalie therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT gannonphilippeo therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT lepagececile therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT saadfred therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT mesmassonannemarie therelbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT laboubaingrid relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT poissonalexis relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT lafontainejulie relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT delvoyenathalie relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT gannonphilippeo relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT lepagececile relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT saadfred relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo
AT mesmassonannemarie relbalternativenfkappabsubunitpromotesautophagyin22rv1prostatecancercellsinvitroandaffectsmousexenografttumorgrowthinvivo